Viveve Medical, Inc.
VIVE
$0.0002
$0.000.00%
OTC PK
| 09/30/2022 | 06/30/2022 | 03/31/2022 | 12/31/2021 | 09/30/2021 | |
|---|---|---|---|---|---|
| Net Income | 15.06% | -43.19% | -1.64% | -33.08% | -56.84% |
| Total Depreciation and Amortization | -28.46% | -42.15% | -37.80% | -27.05% | -21.15% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -20.20% | 1,111.76% | -10.51% | 38.02% | 38.72% |
| Change in Net Operating Assets | -75.72% | -453.15% | -178.93% | 31.47% | 687.36% |
| Cash from Operations | -25.80% | -22.30% | -56.38% | -40.43% | 3.06% |
| Capital Expenditure | -129.76% | -942.86% | 42.35% | 22.22% | 24.32% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -129.76% | -942.86% | 42.35% | 22.22% | 24.32% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -9.52% | -98.15% | -99.92% | -- | -99.42% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | 200.00% | 100.00% |
| Cash from Financing | -9.52% | -98.07% | -99.92% | 1,900.00% | -99.41% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -29.27% | -51.03% | -123.34% | -30.86% | -489.43% |